A recent study reported that a retro-inverso-D-amino acid-based insulin B-chain (9–23) peptide blocked the presentation of native InsB9-23 by HLA-DQ8 to autoreactive T-cells, suggesting that D-amino acid peptides may be an innovative treatment for T1D (27). The gene discussed is INS; the disease is type 1 diabetes mellitus.